Westmount Partners, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2051491
LOS ANGELES, CA
Position in ALNY
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$330,870
-$66,780 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Westmount Partners, LLC holds $1,894,270 across 6 Biotechnology names. ALNY ranks #2 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,961 | $973,241 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,000 | $330,870 | |
| 3 | NTHI |
Neonc Technologies Holdings, Inc.
|
43,320 | $303,673 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,193 | $237,112 | |
| 5 | CRBU |
Caribou Biosciences, Inc.
|
19,609 | $37,257 | |
| 6 | FATE |
Fate Therapeutics Inc
|
10,098 | $12,117 |
All Filings in ALNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $330,870 | 1,000 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $397,650 | 1,000 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $456,000 | 1,000 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $326,090 | 1,000 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $270,020 | 1,000 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $235,310 | 1,000 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $275,030 | 1,000 | Shares | Sole | 2025-01-13 | |
| 2024-06-30 | $244,215 | 1,005 | Shares | Sole | 2025-01-28 | |
| 2023-03-31 | $200,320 | 1,000 | Shares | Sole | 2025-01-29 | |
| 2022-12-31 | $237,650 | 1,000 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||